Novel Taste Masking Technologies in Oral Pharmaceutical

To evaluate the effectiveness of novel taste-masking technologies in developing oral pharmaceuticals with improved patient acceptability and adherence. The study can focus on the formulation and evaluation of different taste-masking technologies, such as microencapsulation, nanotechnology, and ion exchange resins, and compare their ability to mask unpleasant tastes of active pharmaceutical ingredients (APIs). The study can also assess the stability, bioavailability, and safety of the formulated oral pharmaceuticals using in vitro and in vivo methods. The findings can provide insights into the development of taste-masking technologies and their potential use in improving patient outcomes in the pharmaceutical industry. One of the many significant formulation issues with some medications is taste. One of the crucial factors influencing patient compliance is taste. Unpleasant taste is one of the most challenging task to administer medications is orally. Orally administered drugs frequently have a harsh taste. A key factor in determining whether or not the recipient will take the meds is their palatability. Treatments are frequently complicated by patients' incapacity or refusal to ingest solid dosage forms, such as pills, especially in children and the elderly. These dose forms give the patient's taste buds the opportunity to perceive the active medicine ingredients. Because of this, the composition of these treatments disguises the drug's bad taste.